ARTICLE | Distillery Therapeutics
Neurology
November 6, 2018 8:44 PM UTC
In vitro, cell culture and mouse studies identified a PANK3 activator that could help treat pantothenate kinase-associated neurodegeneration (PKAN), which is caused by PANK2 deficiency and leads to lo...
BCIQ Company Profiles